A growing number of in vitro and in vivo preclinical studies have demonstrated the capacity of GLP-1 RAs to inhibit key hallmarks of cancer, including tumour cell proliferation, migration, invasion, and metastatic potential. This evidence concerns the gene GCG and neoplasm.